XML 39 R15.htm IDEA: XBRL DOCUMENT v3.20.1
Stock Based Compensation
3 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
Stock Based Compensation Stock Based Compensation
Stock Options
The following table summarizes stock option activity under our 2013 Equity Incentive Plan (the “2013 Plan”) and our Inducement Plan, and related information during the three months ended March 31, 2020:
 
Shares
Subject to
Outstanding
Options
 
Weighted-
Average Exercise
Price Per Share
Balance at December 31, 2019
7,548,436

 
$
32.21

Options granted
1,689,360

 
12.32

Options exercised
(35,654
)
 
9.12

Options canceled
(401,547
)
 
31.49

Balance at March 31, 2020
8,800,595

 
$
28.52


Performance Stock Options (“PSOs”)
In January 2020, the Compensation Committee of our board of directors approved a program to award PSOs of an aggregate of up to 575,625 shares of our common stock to members of our management team, based on the achievement of certain net revenue goals. The following table summarizes PSO activities under our 2013 Plan and related information during the three months ended March 31, 2020:
 
Shares
Subject to
Outstanding
PSOs
 
Weighted-
Average Exercise
Price Per Share
Balance at December 31, 2019
552,010

 
$
31.43

Options granted
575,625

 
12.79

Options exercised
(2,293
)
 
23.76

Options canceled
(430,799
)
 
33.29

Balance at March 31, 2020
694,543

 
$
14.85


Restricted Stock Units (“RSUs”)
The following table summarizes RSU activity under our 2013 Plan and our Inducement Plan, and related information during the three months ended March 31, 2020:
 
Shares
Subject to
Outstanding
RSUs
 
Weighted-
Average Grant Date
Fair Value Per Share
Balance at December 31, 2019
1,274,217

 
$
29.86

RSUs granted
947,442

 
12.42

RSUs released
(355,665
)
 
31.35

RSUs canceled
(78,246
)
 
26.53

Balance at March 31, 2020
1,787,748

 
$
20.46


Performance Stock Units (“PSUs”)
In January 2020, the Compensation Committee of our board of directors approved an aggregate of 865,500 shares of Market-based PSU ("M-PSU") awards to members of our management team. Each M-PSU represents a contingent right to receive one share of our common stock upon achievement of market-based performance criteria and subject to the recipient’s continued employment. At any time during the three years following the date of the grant: i) one-third of the shares subject to the M-PSUs will vest any time after one year from the grant date if the average closing price of our common stock on the NASDAQ Global Select Market for 20 consecutive trading days has increased 50% per share compared to the grant date closing price, ii) another
one-third of the shares subject to the M-PSUs will vest any time after two years from the grant date if the average closing price of our common stock on the NASDAQ Global Select Market for 20 consecutive trading days has increased 100% per share compared to the grant date closing price, and iii) the last one-third of the shares subject to the M-PSUs will vest three years from the grant date if the average closing price of our common stock on the NASDAQ Global Select Market for 20 consecutive trading days has increased 150% per share compared to the grant date closing price. The estimated M-PSU expense is being recognized on an accelerated basis over the estimated requisite service period, with no adjustments in the future periods based upon our actual common stock price.
The following table summarizes PSU activity under our 2013 Plan and related information during the three months ended March 31, 2020:
 
Subject to
Outstanding
PSUs
 
Weighted-
Average Grant Date
Fair Value Per Share
Balance at December 31, 2019
11,925

 
$
32.66

PSUs granted
865,500

 
13.06

PSUs released
(11,925
)
 
32.66

Balance at March 31, 2020
865,500

 
$
13.06

 
Stock-Based Compensation
The table below sets forth the functional classification of stock-based compensation expense for the periods presented (in thousands):
 
Three Months Ended March 31,
 
2020
 
2019
Research and development
$
2,599

 
$
10,137

Selling, general and administrative
6,881

 
7,757

Stock-based compensation expense included in total expenses
$
9,480

 
$
17,894

 
 
 
 
Capitalized stock-based compensation costs
$
(327
)
 
$
(242
)